Wall Street Zen cut shares of Biodexa Pharmaceuticals (NASDAQ:BDRX – Free Report) from a hold rating to a sell rating in a research report released on Saturday morning. Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Biodexa Pharmaceuticals in a research note on Monday, December 29th. One investment analyst has rated the […]